栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/03 | 2,054 | 2,072 | 2,039 | 2,065 | -14 | -0.7% | 173,600 |
2021/03/02 | 2,100 | 2,101 | 2,070 | 2,079 | -21 | -1% | 126,100 |
2021/03/01 | 2,080 | 2,100 | 2,061 | 2,100 | +70 | +3.4% | 147,400 |
2021/02/26 | 2,080 | 2,085 | 2,030 | 2,030 | -71 | -3.4% | 221,100 |
2021/02/25 | 2,102 | 2,117 | 2,094 | 2,101 | +1 | ±0% | 103,500 |
2021/02/24 | 2,120 | 2,134 | 2,098 | 2,100 | -42 | -2% | 204,900 |
2021/02/22 | 2,188 | 2,191 | 2,120 | 2,142 | +4 | +0.2% | 157,500 |
2021/02/19 | 2,158 | 2,166 | 2,122 | 2,138 | -28 | -1.3% | 97,900 |
2021/02/18 | 2,210 | 2,215 | 2,158 | 2,166 | -51 | -2.3% | 142,000 |
2021/02/17 | 2,175 | 2,218 | 2,161 | 2,217 | +18 | +0.8% | 295,200 |
2021/02/16 | 2,245 | 2,245 | 2,192 | 2,199 | -46 | -2% | 222,700 |
2021/02/15 | 2,264 | 2,264 | 2,227 | 2,245 | -7 | -0.3% | 142,100 |
2021/02/12 | 2,274 | 2,276 | 2,229 | 2,252 | -33 | -1.4% | 193,400 |
2021/02/10 | 2,291 | 2,302 | 2,258 | 2,285 | -53 | -2.3% | 208,300 |
2021/02/09 | 2,340 | 2,340 | 2,309 | 2,338 | -2 | -0.1% | 193,000 |
2021/02/08 | 2,353 | 2,355 | 2,326 | 2,340 | +20 | +0.9% | 144,200 |
2021/02/05 | 2,299 | 2,327 | 2,281 | 2,320 | +3 | +0.1% | 212,000 |
2021/02/04 | 2,355 | 2,373 | 2,315 | 2,317 | -52 | -2.2% | 178,200 |
2021/02/03 | 2,402 | 2,402 | 2,358 | 2,369 | -33 | -1.4% | 179,700 |
2021/02/02 | 2,379 | 2,424 | 2,342 | 2,402 | +21 | +0.9% | 263,900 |
2021/02/01 | 2,302 | 2,383 | 2,301 | 2,381 | +78 | +3.4% | 323,100 |
2021/01/29 | 2,419 | 2,430 | 2,301 | 2,303 | -132 | -5.4% | 784,200 |
2021/01/28 | 2,237 | 2,438 | 2,230 | 2,435 | +398 | +19.5% | 2,077,700 |
2021/01/27 | 2,009 | 2,040 | 2,001 | 2,037 | +45 | +2.3% | 227,800 |
2021/01/26 | 1,997 | 2,004 | 1,985 | 1,992 | -3 | -0.2% | 114,100 |
2021/01/25 | 1,983 | 2,000 | 1,977 | 1,995 | +12 | +0.6% | 86,300 |
2021/01/22 | 1,960 | 1,997 | 1,945 | 1,983 | +6 | +0.3% | 127,200 |
2021/01/21 | 1,959 | 1,986 | 1,934 | 1,977 | +11 | +0.6% | 177,800 |
2021/01/20 | 1,990 | 1,998 | 1,963 | 1,966 | -36 | -1.8% | 144,400 |
2021/01/19 | 2,002 | 2,009 | 1,995 | 2,002 | -8 | -0.4% | 105,000 |
2021/01/18 | 1,989 | 2,012 | 1,982 | 2,010 | +1 | ±0% | 76,000 |
2021/01/15 | 2,035 | 2,041 | 2,002 | 2,009 | -52 | -2.5% | 154,200 |
2021/01/14 | 2,080 | 2,093 | 2,040 | 2,061 | -20 | -1% | 232,600 |
2021/01/13 | 2,029 | 2,087 | 2,022 | 2,081 | +22 | +1.1% | 252,500 |
2021/01/12 | 2,031 | 2,066 | 1,958 | 2,059 | -2 | -0.1% | 408,800 |
2021/01/08 | 2,020 | 2,061 | 2,006 | 2,061 | +61 | +3.1% | 174,700 |
2021/01/07 | 2,021 | 2,031 | 2,000 | 2,000 | -7 | -0.3% | 135,700 |
2021/01/06 | 2,023 | 2,049 | 1,994 | 2,007 | -7 | -0.3% | 138,900 |
2021/01/05 | 2,025 | 2,053 | 2,013 | 2,014 | -15 | -0.7% | 146,700 |
2021/01/04 | 2,040 | 2,040 | 2,004 | 2,029 | -26 | -1.3% | 128,100 |
2020/12/30 | 2,060 | 2,073 | 2,034 | 2,055 | -6 | -0.3% | 101,500 |
2020/12/29 | 2,050 | 2,079 | 2,046 | 2,061 | +2 | +0.1% | 170,400 |
2020/12/28 | 2,048 | 2,067 | 2,045 | 2,059 | +11 | +0.5% | 116,700 |
2020/12/25 | 2,040 | 2,057 | 2,026 | 2,048 | +11 | +0.5% | 109,200 |
2020/12/24 | 2,040 | 2,057 | 2,034 | 2,037 | -10 | -0.5% | 92,600 |
2020/12/23 | 2,029 | 2,056 | 2,029 | 2,047 | +28 | +1.4% | 95,000 |
2020/12/22 | 2,060 | 2,063 | 1,999 | 2,019 | -51 | -2.5% | 195,700 |
2020/12/21 | 2,106 | 2,112 | 2,056 | 2,070 | -45 | -2.1% | 202,200 |
2020/12/18 | 2,100 | 2,133 | 2,084 | 2,115 | +39 | +1.9% | 275,700 |
2020/12/17 | 2,065 | 2,088 | 2,043 | 2,076 | +42 | +2.1% | 254,700 |
901~
950
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム